Abstract
The p50 and p65 subunits of NF-kappa B represent two members of a gene family that shares considerable homology to the rel oncogene. Proteins encoded by these genes form homo- and heterodimers which recognize a common DNA sequence motif. Recent data have suggested that homodimers of individual subunits of NF-kappa B can selectively activate gene expression in vitro. To explore this possibility in a more physiological manner, murine embryonic stem (ES) cells were treated with phosphorothio antisense oligonucleotides to either p50 or p65. Within 5 h after exposure to phosphorothio antisense p65 oligonucleotides, cells exhibited dramatic alterations in adhesion properties. Similar findings were obtained in a stable cell line that expressed a dexamethasone-inducible antisense mRNA to p65. Although antisense oligonucleotides raised against both p50 and p65 elicited a significant reduction in their respective mRNAs, only the cells treated with antisense p50 maintained a normal morphology. However, 6 days following removal of leukemia-inhibiting factor, a growth factor which suppresses embryonic stem cell differentiation, adhesion properties of cells treated with the antisense p50 oligonucleotides were markedly affected. The ability of the individual antisense oligonucleotides to elicit differential effects on cell adhesion, a property dependent upon the stage of differentiation, suggests that the p50 and p65 subunits of NF-kappa B regulate gene expression either as homodimers or as heterodimers with other rel family members. Furthermore, the finding that reduction in p65 expression alone had profound effects on cell adhesion properties indicates that p65 plays an important role in nonstimulated cells and cannot exist solely complexed with the cytosolic inhibitory protein I kappa B.
MeSH Terms
Animals
Base Sequence
Cell Adhesion/drug effects
Cell Differentiation
Cell Line
Cell Nucleus/metabolism
Embryo, Mammalian
Humans
Macromolecular Substances
Mice
Molecular Sequence Data
Multigene Family
NF-kappa B/genetics,metabolism
Oligonucleotides, Antisense/pharmacology
Oncogenes
PC12 Cells
Polymerase Chain Reaction
RNA, Antisense/metabolism
Stem Cells
Thionucleotides
Chemicals
Macromolecular Substances
NF-kappa B
Oligonucleotides, Antisense
RNA, Antisense
Thionucleotides
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Narayanan R
Division of Oncology, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110.
Higgins K A
Perez J R
Coleman T A
Rosen C A
References (29)
29 references, click to expand
-
The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity.
Genes Dev. 1990 Nov;4(11):1975-84
PMID: 2125960
-
Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.
Science. 1992 Dec 11;258(5089):1792-5
PMID: 1299224
-
Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
Science. 1991 Mar 22;251(5000):1490-3
PMID: 2006423
-
Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression.
Genes Dev. 1991 May;5(5):728-40
PMID: 1709130
-
An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.
Nucleic Acids Res. 1991 May 25;19(10):2645-53
PMID: 1710341
-
Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens.
Science. 1986 Apr 18;232(4748):385-8
PMID: 2421406
-
Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7706-10
PMID: 3499613
-
I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
Science. 1988 Oct 28;242(4878):540-6
PMID: 3140380
-
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40
PMID: 2494664
-
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
Cell. 1989 Jul 28;58(2):227-9
PMID: 2665943
-
Nerve growth factor-induced differentiation in PC-12 cells is blocked by fos oncogene.
Oncogene. 1989 Oct;4(10):1193-9
PMID: 2552373
-
Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene.
J Virol. 1990 Jan;64(1):256-63
PMID: 2293664
-
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Genes Dev. 1989 Nov;3(11):1689-98
PMID: 2691328
-
Modulation of eukaryotic gene expression by complementary RNA or DNA sequences.
Biotechniques. 1988 Nov-Dec;6(10):958-76
PMID: 2483657
-
Specific regulation of gene expression by antisense, sense and antigene nucleic acids.
Biochim Biophys Acta. 1990 Jun 21;1049(2):99-125
PMID: 1694695
-
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
Cell. 1990 Sep 7;62(5):1007-18
PMID: 2203531
-
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
Cell. 1990 Sep 7;62(5):1019-29
PMID: 2203532
-
The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Cell. 1990 Nov 16;63(4):803-14
PMID: 2225078
-
Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture.
Development. 1991 Feb;111(2):259-67
PMID: 1893864
-
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
J Biol Chem. 1991 Sep 25;266(27):18162-71
PMID: 1680858
-
Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester.
J Immunol. 1991 Oct 15;147(8):2777-86
PMID: 1680919
-
Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.
Mol Cell Biol. 1992 Feb;12(2):444-54
PMID: 1732726
-
The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1875-9
PMID: 1542686
-
Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.
Oncogene. 1992 Mar;7(3):553-61
PMID: 1549369
-
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
Genes Dev. 1992 May;6(5):761-74
PMID: 1577271
-
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Genes Dev. 1992 May;6(5):775-87
PMID: 1577272
-
Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
Mol Cell Biol. 1992 Oct;12(10):4412-21
PMID: 1406630
-
Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation.
Cell Growth Differ. 1992 Sep;3(9):609-16
PMID: 1419911
-
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
Cell. 1991 Mar 8;64(5):961-9
PMID: 2001591